World Vapers’ Alliance
2.4.2026 18:39:14 CEST | Globenewswire | Press release
Cherry-Picking Science: WVA Condemns EU Tobacco Report
Cherry-Picking Science: WVA Condemns EU Tobacco Report
BRUSSELS, April 02, 2026 (GLOBE NEWSWIRE) -- The European Commission’s newly released evaluation of the Tobacco Products Directive (TPD) is facing sharp criticism from the World Vapers’ Alliance (WVA) for what it describes as a "masterclass in cherry-picking science". The report, intended to serve as the evidentiary foundation for a total revision of EU tobacco laws, celebrates a 14.3% decline in smoking across the bloc since 2012 as a policy success.
However, the WVA points out a massive disparity in results: this very week, Sweden announced its smoking rate has plummeted to a record low of 3.7%. While the rest of the EU settles for incremental progress, Sweden has slashed its smoking rate by 66% over the same period. This was achieved by embracing tobacco harm reduction and allowing less harmful alternatives like nicotine pouches and vaping to compete with cigarettes.
"This report is an insult to science and a betrayal of the millions of (former) smokers across Europe," said Michael Landl, Director of the World Vapers’ Alliance. "It is peak irony that while Brussels touts a 14% decline and prepares new bans, Sweden became smoke-free. This document is a 144-page exercise in ideological blindness designed to justify banning the very alternatives that work."
The World Vapers’ Alliance is now urging the Commission to abandon its "prohibitionist fantasy" and return to the grounds of scientific reality. “We warn that a TPD revision built on this dishonest foundation will ensure that tobacco-related mortality remains a permanent fixture of European life”, added Landl.
Contact:
Michael Landl, Director, World Vapers’ Alliance
info@worldvapersalliance.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/23d44cef-b934-4430-a66e-f7a36a326666

Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S3.10.2026 21:40:00 CEST | Press release
Genmab Announces Rinatabart Sesutecan (Rina-S®) Phase 2 RAINFOL™-01 Results Demonstrated Durable and Clinically Meaningful Responses in Patients with Platinum-Resistant Ovarian Cancer
Chery Group3.10.2026 14:28:18 CEST | Press release
FREELANDER Marks a New Chapter at Its Global Brand Launch in Abu Dhabi
Chery Group3.10.2026 14:16:10 CEST | Press release
FREELANDER Sets Out Its International Roadmap with a Phased Expansion from the Middle East
Chery Auto3.10.2026 10:47:01 CEST | Press release
LEPAS Enters Romania: LEPAS L8 PHEV Officially Launches as First Flagship Store Opens
Novo Nordisk A/S2.10.2026 22:53:42 CEST | Press release
Novo provides update on the denecimig Biologics License Application (BLA) in the US
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom